Capstone Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,500
Closed -$1.86M 1599
2024
Q4
$1.86M Buy
4,500
+1,100
+32% +$482K ﹤0.01% 867
2024
Q3
$1.72M Buy
3,400
+400
+13% +$194K 0.01% 783
2024
Q2
$1.46M Buy
3,000
+1,400
+88% +$703K ﹤0.01% 839
2024
Q1
$864K Hold
1,600
﹤0.01% 1236
2023
Q4
$888K Sell
1,600
-500
-24% -$235K ﹤0.01% 1100
2023
Q3
$918K Buy
2,100
+600
+40% +$299K ﹤0.01% 1013
2023
Q2
$753K Buy
1,500
+200
+15% +$95.8K ﹤0.01% 977
2023
Q1
$650K Buy
1,300
+800
+160% +$383K ﹤0.01% 927
2022
Q4
$204K Sell
500
-600
-55% -$233K ﹤0.01% 1295
2022
Q3
$358K Buy
1,100
+500
+83% +$184K ﹤0.01% 1363
2022
Q2
$210K Sell
600
-700
-54% -$285K ﹤0.01% 1404
2022
Q1
$711K Sell
1,300
-500
-28% -$263K ﹤0.01% 1420
2021
Q4
$1.19M Sell
1,800
-3,100
-63% -$1.95M ﹤0.01% 1255
2021
Q3
$3.05M Buy
4,900
+4,700
+2,350% +$3.16M 0.01% 1039
2021
Q2
$126K Sell
200
-5,100
-96% -$2.82M ﹤0.01% 1545
2021
Q1
$2.59M Sell
5,300
-700
-12% -$351K 0.01% 845
2020
Q4
$3M Buy
6,000
+700
+13% +$313K 0.01% 756
2020
Q3
$2.08M Buy
5,300
+600
+13% +$222K 0.01% 793
2020
Q2
$1.55M Buy
+4,700
New +$1.36M 0.01% 788
2020
Q1
Sell
-3,000
Closed -$783K 1255
2019
Q4
$783K Sell
3,000
-3,100
-51% -$817K ﹤0.01% 1055
2019
Q3
$1.66M Buy
6,100
+2,800
+85% +$779K 0.01% 780
2019
Q2
$909K Hold
3,300
0.01% 975
2019
Q1
$738K Buy
3,300
+2,600
+371% +$537K 0.01% 901
2018
Q4
$130K Buy
700
+100
+17% +$20.5K ﹤0.01% 1088
2018
Q3
$150K Buy
+600
New +$146K ﹤0.01% 1068

Other funds holding IDXX

Capstone Investment Advisors's IDXX Position: Q3 2025 in Review

Capstone Investment Advisors sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 2,310 shares — an estimated $1.4M sold.

Capstone Investment Advisors first reported a position in IDXX in Q2 2016 and held it in 18 quarters. The position peaked at $5.1M in Q1 2017. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Capstone Investment Advisors reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,310 Idexx Laboratories shares in Q3 2025, an estimated $1.4M.
  • Capstone Investment Advisors first reported a position in Idexx Laboratories in Q2 2016 and held it in 18 quarters.
  • Capstone Investment Advisors's Idexx Laboratories position peaked at $5.1M in Q1 2017.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Capstone Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.